Medicinal products for gene therapies
Original notice title
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Opportunity Score
Why this score?
Opportunity
68 / 100
Complexity
78 / 100
Risk factors
The notice identifies annual turnover for Lot 1 and works performed for Lot 2, but provides no thresholds, periods, evi...
Electronic submission is required and the XML notice states that no more than one lot may be submitted for or awarded.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Dirección General de Recursos Económicos del Servicio Canario de la Salud
- Country
- Spain
- CPV
- 33690000 - Various medicinal products
- Deadline
- Apr 17, 2031
- Estimated value
- EUR 65.8M
Overview
Moderate opportunityKey Facts
- EUR 65.8M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 2 lots
- Duration until Apr 2031
- Supply of advanced gene-therapy medicines.
- Lot 1 concerns therapy for spinal muscular atrophy.
Show full summary
Restricted electronic procurement for a dynamic purchasing system covering advanced gene-therapy medicines for spinal muscular atrophy and haemophilia B patients of the Canary Health Service. There are two lots, with a combined estimated value of EUR 65,765,376 and a stated submission deadline of 17 April 2031. The award criterion is price only, weighted at 100%. The procurement documents themselves were not provided for analysis; only structured data and a TED XML notice were available.
Risks
The notice identifies annual turnover for Lot 1 and works performed for Lot 2, but provides no thresholds, periods, evi...
Electronic submission is required and the XML notice states that no more than one lot may be submitted for or awarded.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Electronic submission is required through the Spanish public procurement platform.
- Submission language is Spanish.
- The maximum number of lots that may be submitted for and awarded is stated in the XML notice as one.
Award Criteria
Lot 1
Lot 2
Buyer
Location
Las Palmas de Gran Canaria, ESP
Buyer profile
Identifier
21058580149618
Activity
Health
Lots (2)
LOT-0001
Gene therapy for spinal muscular atrophy
Supply of gene therapy medicines for the treatment of spinal muscular atrophy. The lot is operated through a dynamic purchasing system and has a planned performance period from April 2026 to April 2031.
EUR 65.8M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
precio. . Precio.
Value note
Show original TED data
Original lot title
Terapia génica para la atrofia muscular espinal
Original TED description
Terapia génica para la atrofia muscular espinal
LOT-0002
Gene therapy for haemophilia B
Supply of gene therapy medicines for the treatment of haemophilia B. The lot is operated through a dynamic purchasing system and has a planned performance period from April 2026 to April 2031.
EUR 65.8M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
precio. . Price.
Value note
Show original TED data
Original lot title
Terapia génica para la hemofilia B
Original TED description
Terapia génica para la hemofilia B
Procurement Details
- Publication date
- 19 Apr 2026
- Languages
- Spanish
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 267052-2026
Documents (1)
Similar tenders
Poland – Various medicinal products – Dostawa produktów leczniczych, leków do chemioterapii dla USK-1 w Szczecinie
Romania – Various medicinal products – Acord-cadru de furnizare medicamente - Spitalul Orasenesc Panciu
Romania – Various medicinal products – Medicamente diverse 14
Lithuania – Various medicinal products – Vaistiniai preparatai (DMSA)
Poland – Pharmaceutical products – Dostawa produktów leczniczych do magazynu apteki szpitalnej SPZOZ w Radzyniu Podlaskim
Poland – Various medicinal products – Dostawa produktów leczniczych, leków do programów lekowych oraz chemioterapii dla USK-1 w Szczecinie
Opportunity Score
Why this score?
Opportunity
68 / 100
Complexity
78 / 100
Risk factors
The notice identifies annual turnover for Lot 1 and works performed for Lot 2, but provides no thresholds, periods, evi...
Electronic submission is required and the XML notice states that no more than one lot may be submitted for or awarded.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications